March 22, 2022 -- Twist Bioscience has launched synthetic RNA positive controls for SARS-CoV-2 encapsulated in proprietary stainless steel minicapsules provided by Imagene SA.
The design enables enhanced storage and transportation and cost-efficiency. The synthetic controls, which are designed based on specific SARS-CoV-2 variants, cover the full viral genome and are sequence-verified.